The TachyNA™ Plasma cfNA Kit isolates circulating cell-free nucleic acids — cfDNA and cfRNA — from plasma and serum in under ten minutes — from as little as 50 µL of sample.
Three things matter to a cfDNA workflow: speed, yield, and recovery of small fragments. TachyNA™ delivers on all three.
Biomics Inc. announces the commercial release of the TachyNA™ Plasma cfNA Kit (Cat. No. H02CN1), built on our proprietary NA-DP™ Direct Pass membrane chemistry. The kit isolates circulating cell-free nucleic acids (cfDNA and cfRNA) from as little as 50 µL of plasma or serum in under ten minutes — delivering higher yield and markedly better recovery of short cfDNA fragments than conventional silica-column and magnetic-bead workflows.
cfDNA isolation has three failure modes that matter to your workflow: it's slow, you lose yield, and small fragments — the ones that often carry the signal — never make it through. TachyNA™ was designed to solve all three.
Manual workflow under ten minutes. Streamlined steps with no tedious bind–wash–elute cycle. Run more samples per shift, or reclaim hours of bench time.
More total nucleic acid recovered per run, especially when input is precious. Lower Ct in qPCR and richer NGS signal — with no volume-concentration step.
cfDNA carries diagnostic signal in the short-fragment range — exactly where silica chemistry loses recovery. TachyNA™ captures these fragments without selective loss.
The TachyNA™ Plasma cfNA Kit is a next-generation purification system for circulating cell-free DNA from human plasma and serum. It uses our proprietary NA-DP™ (Nucleic Acid Direct Pass) technology — a fundamentally different approach to nucleic acid sample preparation, refined over more than a decade of separation-chemistry development.
The result: a streamlined, single-pass extraction with strong recovery, robust short-fragment capture, and broad workflow compatibility — manual centrifuge, syringe POCT, vacuum manifold, or liquid-handling automation. Same kit, same cfDNA, the way you already work.
Single-pass extraction
Most cfDNA kits are silica-binding chemistries originally designed for genomic DNA, then adapted for cell-free DNA. TachyNA™ was designed for cfDNA from the start — which is why it performs differently on the things that matter.
| What matters to your workflow | TachyNA™ | Silica column | Magnetic beads |
|---|---|---|---|
| Recovery from low-volume input (50–100 µL) | Excellent | Moderate | Moderate |
| Short-fragment recovery (< 200 bp) | Excellent | Moderate | Moderate |
| DNA loss during purification | Minimal | High | Moderate |
| PCR-inhibitor removal | Excellent | Moderate | Moderate |
| POCT (point-of-care) suitability | Excellent | Low | Low |
| Automation flexibility | Excellent | Moderate | High |
| Workflow simplicity | High | Moderate | Moderate |
Comparative claims reflect Biomics internal head-to-head testing under matched conditions. Full datasets available on request to qualified customers under NDA. Reference to third-party product categories is for comparison only.
TachyNA™ is in active use across research and translational laboratories — in oncology, women's health, transplant medicine, and infectious disease. Anywhere input is precious, fragments are short, and clean signal matters.
ctDNA analysis, minimal residual disease detection, recurrence and therapy-response monitoring.
Non-invasive prenatal screening workflows that depend on consistent cfDNA recovery from plasma.
dd-cfDNA monitoring for graft surveillance after solid-organ transplantation.
Bloodstream pathogen nucleic-acid detection — bacterial, viral, and fungal cell-free DNA.
Mutation profiling and patient-stratification studies dependent on robust cfDNA recovery.
Fragmentomics, methylomics, and epigenetic profiling where short-fragment recovery is critical.
Whether you have a technical question, need a quote, or want to explore a partnership, our technical and customer service team is ready to help.
Specs, applications, validation data, downstream compatibility.
Order H02CN1 (50 tests), request the H02CN1-E evaluation kit, or ask about volume pricing.
Distribution territories, channel programs, and NA-DP™ co-development.
info@biomicsinc.com · Biomics Inc. · 29540 Kohoutek Way, Union City, CA 94587 · United States
